Literature DB >> 18057139

What can we learn from rodents about prolactin in humans?

Nira Ben-Jonathan1, Christopher R LaPensee, Elizabeth W LaPensee.   

Abstract

Prolactin (PRL) is a 23-kDa protein hormone that binds to a single-span membrane receptor, a member of the cytokine receptor superfamily, and exerts its action via several interacting signaling pathways. PRL is a multifunctional hormone that affects multiple reproductive and metabolic functions and is also involved in tumorigenicity. In addition to being a classical pituitary hormone, PRL in humans is produced by many tissues throughout the body where it acts as a cytokine. The objective of this review is to compare and contrast multiple aspects of PRL, from structure to regulation, and from physiology to pathology in rats, mice, and humans. At each juncture, questions are raised whether, or to what extent, data from rodents are relevant to PRL homeostasis in humans. Most current knowledge on PRL has been obtained from studies with rats and, more recently, from the use of transgenic mice. Although this information is indispensable for understanding PRL in human health and disease, there is sufficient disparity in the control of the production, distribution, and physiological functions of PRL among these species to warrant careful and judicial extrapolation to humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057139      PMCID: PMC2244934          DOI: 10.1210/er.2007-0017

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  406 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

2.  A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.

Authors:  W Y Chen; P Ramamoorthy; N Chen; R Sticca; T E Wagner
Journal:  Clin Cancer Res       Date:  1999-11       Impact factor: 12.531

3.  Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.

Authors:  Trino Baptista; Emma Araujo de Baptista; Josee Lalonde; Julie Plamondon; N M K Ng Ying Kin; Serge Beaulieu; Rhida Joober; Denis Richard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-12       Impact factor: 5.067

4.  PRL modulates cell cycle regulators in mammary tumor epithelial cells.

Authors:  Matthew D Schroeder; Jaime Symowicz; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2002-01

5.  Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.

Authors:  S W Lamberts; T Verleun; L Hofland; R Oosterom
Journal:  J Clin Endocrinol Metab       Date:  1986-12       Impact factor: 5.958

6.  Integration of lipid metabolism in the mammary gland and adipose tissue by prolactin during lactation.

Authors:  M Ros; M F Lobato; J P García-Ruíz; F J Moreno
Journal:  Mol Cell Biochem       Date:  1990-03-27       Impact factor: 3.396

7.  Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript.

Authors:  B Gellersen; G E DiMattia; H G Friesen; H G Bohnet
Journal:  Mol Cell Endocrinol       Date:  1989-06       Impact factor: 4.102

8.  Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.

Authors:  T Clark Brelje; Laurence E Stout; Nicholas V Bhagroo; Robert L Sorenson
Journal:  Endocrinology       Date:  2004-05-13       Impact factor: 4.736

9.  Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Authors:  Shelley S Tworoger; A Heather Eliassen; Bernard Rosner; Patrick Sluss; Susan E Hankinson
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

10.  PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.

Authors:  Carolina Cristina; Graciela S Díaz-Torga; Rodolfo G Goya; Sham S Kakar; María I Perez-Millán; Vanessa Q Passos; Daniel Giannella-Neto; Marcello D Bronstein; Damasia Becu-Villalobos
Journal:  Mol Cancer       Date:  2007-01-12       Impact factor: 27.401

View more
  150 in total

1.  Correlation of serum prolactin levels and disease activity in systematic lupus erythematosus.

Authors:  Mansoor Karimifar; Afshin Tahmasebi; Zahra Sayed Bonakdar; Samaneh Purajam
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?

Authors:  Ignacio Bernabeu; Felipe F Casanueva
Journal:  Endocrine       Date:  2013-08-22       Impact factor: 3.633

3.  Prolactin receptor gene polymorphisms are associated with gestational diabetes.

Authors:  Trang N Le; Sarah H Elsea; Roberto Romero; Tinnakorn Chaiworapongsa; Gary L Francis
Journal:  Genet Test Mol Biomarkers       Date:  2013-05-07

Review 4.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

Review 5.  Does exercise have a role in the management of gestational diabetes mellitus?

Authors:  Herbert Groeller; Sandra Lowe; Anthony Worsley; Arthur Jenkins
Journal:  Obstet Med       Date:  2010-12-03

6.  Expression of prolactin receptors in the duodenum, kidneys and skeletal system during physiological and sulpiride-induced hyperprolactinaemia.

Authors:  Danijela Radojkovic; Milica Pesic; Milan Radojkovic; Dragan Dimic; Marija Vukelic Nikolic; Tatjana Jevtovic Stoimenov; Sasa Radenkovic; Milena Velojic Golubovic; Tatjana Radjenovic Petkovic; Slobodan Antic
Journal:  Endocrine       Date:  2018-08-24       Impact factor: 3.633

7.  Wild-type offspring of heterozygous prolactin receptor-null female mice have maladaptive β-cell responses during pregnancy.

Authors:  Carol Huang
Journal:  J Physiol       Date:  2012-12-17       Impact factor: 5.182

8.  Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

Authors:  Elizabeth W LaPensee; Sandy J Schwemberger; Christopher R LaPensee; El Mustapha Bahassi; Scott E Afton; Nira Ben-Jonathan
Journal:  Carcinogenesis       Date:  2009-05-14       Impact factor: 4.944

9.  Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.

Authors:  Y Sangeeta Devi; Aurora Shehu; Julia Halperin; Carlos Stocco; Jamie Le; Anita M Seibold; Geula Gibori
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

10.  Prolactin and male fertility: the long and short feedback regulation.

Authors:  M K Gill-Sharma
Journal:  Int J Endocrinol       Date:  2009       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.